A silver lining of neuroinflammation: Beneficial effects on myelination

Experimental Neurology

Volumn 283, Issue , 2016, Pages 550-559

  Goldstein, Evan Z ^a   Church, Jamie S ^a   Hesp, Zoe C ^a   Popovich, Phillip G ^a   McTigue, Dana M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cytokines; Growth factors; Iron; Macrophages; Microglia; Oligodendrocyte; Peripheral nerve; Progenitor; Schwann cells; Spinal cord injury

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; MYELIN; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; SIGNAL PEPTIDE;

CELL DAMAGE; CELL INFILTRATION; CELL LINEAGE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DRUG DESIGN; DRUG EFFECT; HUMAN; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MACROPHAGE FUNCTION; MYELINATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NONHUMAN; OLIGODENDROCYTE PROGENITOR; OLIGODENDROGENESIS; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; REMYELINIZATION; REVIEW; SCHWANN CELL; TARGET CELL; ANIMAL; COMPLICATION; INFLAMMATION; METABOLISM; MYELIN SHEATH; PATHOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; SYNAPTIC TRANSMISSION; TRAUMA, NERVOUS SYSTEM;

EID: 84969506735     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2016.05.001     Document Type: Review

References (173)

1. Amaral, A.I., Hadera, M.G., Tavares, J.M., Kotter, M.R.N., Sonnewald, U., Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells. Glia 64 (2015), 21–34, 10.1002/glia.22900.
2. Arnett, H.A., Mason, J., Marino, M., Suzuki, K., Matsushima, G.K., Ting, J.P.Y., TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 (2001), 1116–1122, 10.1038/nn738.
3. Asakura, K., Miller, D.J., Pease, L.R., Rodriguez, M., Targeting of IgMκ antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18 (1998), 7700–7708.
4. Avellino, A.M., Hart, D., Dailey, A.T., MacKinnon, M., Ellegala, D., Kliot, M., Differential macrophage responses in the peripheral and central nervous system during Wallerian degeneration of axons. Exp. Neurol. 136 (1995), 183–198, 10.1006/exnr.1995.1095.
5. Azari, M.F., Profyris, C., Karnezis, T., Bernard, C.C., Small, D.H., Cheema, S.S., Ozturk, E., Hatzinisiriou, I., Petratos, S., Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J. Neuropathol. Exp. Neurol. 65 (2006), 914–929, 10.1097/01.jnen.0000235855.77716.25.
6. Baer, A.S., Syed, Y.A., Kang, S.U., Mitteregger, D., Vig, R., Ffrench-Constant, C., Franklin, R.J.M., Altmann, F., Lubec, G., Kotter, M.R., Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132 (2009), 465–481, 10.1093/brain/awn334.
7. Banisadr, G., Frederick, T.J., Freitag, C., Ren, D., Jung, H., Miller, S.D., Miller, R.J., The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol. Dis. 44 (2011), 19–27, 10.1016/j.nbd.2011.05.019.
8. Barres, B.A., Schmid, R., Sendnter, M., Raff, M.C., Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118 (1993), 283–295.
9. Beattie, M.S., Bresnahan, J.C., Komon, J., Tovar, C.A., Van Meter, M., Anderson, D.K., Faden, A.I., Hsu, C.Y., Noble, L.J., Salzman, S., Young, W., Endogenous repair after spinal cord contusion injuries in the rat. Exp. Neurol. 148 (1997), 453–463, 10.1006/exnr.1997.6695.
10. Bieber, A.J., Kerr, S., Rodriguez, M., Efficient central nervous system remyelination requires T cells. Ann. Neurol. 53 (2003), 680–684.
11. Blakemore, W.F., Franklin, R.J.M., Remyelination in experimental models of toxin-induced demyelination. Curr. Top. Microbiol. Immunol. 318 (2008), 193–212.
12. Blight, A.R., Young, W., Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J. Neurol. Sci. 91 (1989), 15–34.
13. Brook, G.A., Plate, D., Franzen, R., Martin, D., Spontaneous longitudinally orientated axonal regeneration is associated with the Schwann cell framework within the lesion site following spinal cord compression injury of the rat. J. Neurosci. Res. 53 (1998), 51–65.
14. Bunge, M.B., Wood, P.M., Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury. Spinal Cord Injury, first ed., 2013, Elsevier B.V., 10.1016/B978-0-444-52137-8.00032-2.
15. Calderon, T.M., Eugenin, E.A., Lopez, L., Kumar, S.S., Hesselgesser, J., Raine, C.S., Berman, J.W., A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177 (2006), 27–39, 10.1016/j.jneuroim.2006.05.003.
16. Campana, W.M., Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav. Immun. 21 (2007), 522–527.
17. Carbajal, K.S., Schaumburg, C., Strieter, R., Kane, J., Lane, T.E., Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 11068–11073, 10.1073/pnas.1006375107.
18. Carbajal, K.S., Miranda, J.L., Tsukamoto, M.R., Lane, T.E., CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 59 (2011), 1813–1821, 10.1002/glia.21225.
19. Chari, D.M., Zhao, C., Kotter, M.R., Blakemore, W.F., Franklin, R.J.M., Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system. J. Neurosci. Res. 83 (2006), 594–605, 10.1002/jnr.20763.
20. Charo, I.F., Ransohoff, R.M., The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006), 610–621.
21. Church, J.S., Kigerl, K.A., Lerch, J.K., Popovich, P.G., McTigue, D.M., TLR4 deficiency impairs oligodendrocyte formation in the injured spinal cord. J. Neurosci., 2016 in press.
22. Connor, J.R., Menzies, S.L., Relationship of iron to oligodendrocytes and myelination. Glia 17 (1996), 83–93.
23. Connor, J.R., Pavlick, G., Karli, D., Menzies, S.L., Palmer, C., A histochemical study of iron-positive cells in the developing rat brain. J. Comp. Neurol. 355 (1995), 111–123, 10.1002/cne.903550112.
24. Crawford, A.H., Tripathi, R.B., Foerster, S., McKenzie, I., Kougioumtzidou, E., Grist, M., Richardson, W.D., Franklin, R.J.M., Pre-existing mature oligodendrocytes do not contribute to remyelination following toxin-induced spinal cord demyelination. Am. J. Pathol. 186 (2016), 511–516, 10.1016/j.ajpath.2015.11.005.
25. David, S., Kroner, A., Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12 (2011), 388–399, 10.1038/nrn3053.
26. Deng, Y.P., Sun, Y., Hu, L., Li, Z.H., Xu, Q.M., Pei, Y.L., Huang, Z.H., Yang, Z.G., Chen, C., Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury. Exp. Neurol. 269 (2015), 213–223, 10.1016/j.expneurol.2015.03.026.
27. Deverman, B.E., Patterson, P.H., Cytokines and CNS development. Neuron 64 (2009), 61–78, 10.1016/j.neuron.2009.09.002.
28. Deverman, B.E., Patterson, P.H., Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. J. Neurosci. 32 (2012), 2100–2109, 10.1523/JNEUROSCI.3803-11.2012.
29. Diemel, L.T., Copelman, C.A., Cuzner, M.L., Macrophages in CNS remyelination: friend or foe?. Neurochem. Res. 23 (1998), 341–347.
30. Döring, A., Sloka, S., Lau, L., Mishra, M., van Minnen, J., Zhang, X., Kinniburgh, D., Rivest, S., Yong, V.W., Stimulation of monocytes, macrophages, and microglia by amphotericin B and macrophage colony-stimulating factor promotes remyelination. J. Neurosci. 35 (2015), 1136–1148, 10.1523/JNEUROSCI.1797-14.2015.
31. Dubovy, P., Klusáková, I., Hradilová Svíženská, I., Inflammatory profiling of Schwann cells in contact with growing axons distal to nerve injury. BioMed Res. Int. 2014 (2014), 1–7, 10.1046/j.1460-9568.1998.00277.x.
32. Duncan, I.D., Lunn, K.F., Holmgren, B., Urba-Holmgren, R., Brignolo-Holmes, L., The taiep rat: a myelin mutant with an associated oligodendrocyte microtubular defect. J. Neurocytol. 21 (1992), 870–884.
33. Dziembowska, M., Tham, T.N., Lau, P., Vitry, S., Lazarini, F., Dubois-Dalcq, M., A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50 (2005), 258–269, 10.1002/glia.20170.
34. Espinosa-Jeffrey, A., Kumar, S., Zhao, P.M., Awosika, O., Agbo, C., Huang, A., Chang, R., de Vellis, J., Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat. Dev. Neurosci. 24 (2002), 227–241.
35. Felts, P.A., Woolston, A.-M., Fernando, H.B., Asquith, S., Gregson, N.A., Mizzi, O.J., Smith, K.J., Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128 (2005), 1649–1666, 10.1093/brain/awh516.
36. Filipovic, R., Zecevic, N., Lipopolysaccharide affects golli expression and promotes proliferation of oligodendrocyte progenitors. Glia 49 (2005), 457–466, 10.1002/glia.20125.
37. Filipovic, R., Jakovcevski, I., Zecevic, N., GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev. Neurosci. 25 (2003), 279–290.
38. Foote, A.K., Blakemore, W.F., Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 (2005), 528–539, 10.1093/brain/awh417.
39. Franco, P.G., Pasquini, L.A., Pérez, M.J., Rosato-Siri, M.V., Silvestroff, L., Pasquini, J.M., Paving the way for adequate myelination: the contribution of galectin-3, transferrin and iron. FEBS Lett. 589 (2015), 3388–3395, 10.1016/j.febslet.2015.08.001.
40. Fünfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., Brinkmann, B.G., Kassmann, C.M., Tzvetanova, I.D., Möbius, W., Diaz, F., Meijer, D., Suter, U., Hamprecht, B., Sereda, M.W., Moraes, C.T., Frahm, J., Goebbels, S., Nave, K.-A., Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 (2012), 517–521, 10.1038/nature11007.
41. Gaudet, A.D., Popovich, P.G., Ramer, M.S., Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J. Neuroinflammation 8 (2011), 1–13, 10.1186/1742-2094-8-110.
42. Gay, N.J., Keith, F.J., Drosophila Toll and IL-1 receptor. Nature 351 (1991), 355–356.
43. Gensel, J.C., Nakamura, S., Guan, Z., van Rooijen, N., Ankeny, D.P., Popovich, P.G., Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 29 (2009), 3956–3968, 10.1523/JNEUROSCI.3992-08.2009.
44. Ghasemlou, N., Jeong, S.Y., Lacroix, S., David, S., T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 55 (2007), 294–302.
45. Glezer, I., Rivest, S., Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites. Brain Behav. Immun. 24 (2010), 695–704, 10.1016/j.bbi.2010.01.005.
46. Glezer, I., Lapointe, A., Rivest, S., Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20 (2006), 750–752, 10.1096/fj.05-5234fje.
47. Gloire, G., Legrand-Poels, S., Piette, J., NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006), 1493–1505, 10.1016/j.bcp.2006.04.011.
48. Goethals, S., Ydens, E., Timmerman, V., Janssens, S., Toll-like receptor expression in the peripheral nerve. Glia 58 (2010), 1701–1709, 10.1002/glia.21041.
49. Goodin, D.S., Glucocorticoid treatment of multiple sclerosis. Spinal Cord Injury, first ed., 2014, Elsevier B.V., 10.1016/B978-0-444-52001-2.00020-0.
50. Graça, D.L., Blakemore, W.F., Delayed remyelination in rat spinal cord following ethidium bromide injection. Neuropathol. Appl. Neurobiol. 12 (1986), 593–605.
51. Griffin, J.W., Thompson, W.J., Biology and pathology of nonmyelinating Schwann cells. Glia 56 (2008), 1518–1531, 10.1002/glia.20778.
52. Guest, J.D., Hiester, E.D., Bunge, R.P., Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192 (2005), 384–393, 10.1016/j.expneurol.2004.11.033.
53. He, L., Lu, Q.R., Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci. Bull. 29 (2013), 129–143, 10.1007/s12264-013-1318-y.
54. Hendriks, J.J.A., Slaets, H., Carmans, S., de Vries, H.E., Dijkstra, C.D., Stinissen, P., Hellings, N., Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J. Neuroimmunol. 204 (2008), 52–57, 10.1016/j.jneuroim.2008.07.015.
55. Herx, L.M., Rivest, S., Yong, V.W., Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 is required for the production of ciliary neurotrophic factor. J. Immunol. 165 (2000), 2232–2239, 10.4049/jimmunol.165.4.2232.
56. Hinks, G.L., Franklin, R.J.M., Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol. Cell. Neurosci. 16 (2000), 542–556, 10.1006/mcne.2000.0897.
57. Hosking, M.P., Tirotta, E., Ransohoff, R.M., Lane, T.E., CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS ONE, 5, 2010, e11340, 10.1371/journal.pone.0011340.s003.
58. Imitola, J., Raddassi, K., Park, K.I., Mueller, F.-J., Nieto, M., Teng, Y.D., Frenkel, D., Li, J., Sidman, R.L., Walsh, C.A., Snyder, E.Y., Khoury, S.J., Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 18117–18122, 10.1073/pnas.0408258102.
59. Ishibashi, T., Lee, P.R., Baba, H., Fields, R.D., Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve. J. Neurosci. Res. 87 (2009), 3343–3355, 10.1002/jnr.22173.
60. Janssens, K., Maheshwari, A., Van den Haute, C., Baekelandt, V., Stinissen, P., Hendriks, J.J.A., Slaets, H., Hellings, N., Oncostatin M protects against demyelination by inducing a protective microglial phenotype. Glia 63 (2015), 1729–1737, 10.1002/glia.22840.
61. Jeong, H.-K., Ji, K.-m., Kim, J., Jou, I., Joe, E.-H., Repair of astrocytes, blood vessels, and myelin in the injured brain: possible roles of blood monocytes. Mol. Brain, 6, 2013, 28, 10.1186/1756-6606-6-28.
62. Jessen, K.R., Mirsky, R., Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56 (2008), 1552–1565, 10.1002/glia.20761.
63. Kadi, L., Selvaraju, R., de Lys, P., Proudfoot, A.E.I., Wells, T.N.C., Boschert, U., Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J. Neuroimmunol. 174 (2006), 133–146, 10.1016/j.jneuroim.2006.01.011.
64. Kahn, M.A., De Vellis, J., Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12 (1994), 87–98.
65. Keirstead, H.S., Blakemore, W.F., Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56 (1997), 1191–1201.
66. Kerr, B.J., Patterson, P.H., Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51 (2005), 73–79, 10.1002/glia.20177.
67. Kerstetter, A.E., Padovani-Claudio, D.A., Bai, L., Miller, R.H., Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp. Neurol. 220 (2009), 45–56, 10.1016/j.expneurol.2009.07.010.
68. Kidd, G.J., Ohno, N., Trapp, B.D., Biology of Schwann cells. Spinal Cord Injury, first ed., 2013, Elsevier B.V., 10.1016/B978-0-444-52902-2.00005-9.
69. Kigerl, K.A., Popovich, P.G., Toll-like receptors in Spinal Cord Injury. Current Topics in Microbiology and Immunology. 2009, Springer Berlin Heidelberg, Berlin, Heidelberg, 121–136, 10.1007/978-3-642-00549-7_7.
70. Kigerl, K.A., Lai, W., Rivest, S., Hart, R.P., Satoskar, A.R., Popovich, P.G., Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102 (2007), 37–50, 10.1111/j.1471-4159.2007.04524.x.
71. Kigerl, K.A., Gensel, J.C., Ankeny, D.P., Alexander, J.A., Donnelly, D.J., Popovich, P.G., Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29 (2009), 13435–13444.
72. − regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp. Neurol. 233 (2012), 333–341, 10.1016/j.expneurol.2011.10.025.
73. Kim, J., Lee, H., Park, H., Two faces of Schwann cell dedifferentiation in peripheral neurodegenerative diseases: pro-demyelinating and axon-preservative functions. Neural Regen. Res. 9 (2014), 1952–1953, 10.4103/1673-5374.145370.
74. Kondo, Y., Adams, J.A., Vanier, M.T., Duncan, I.D., Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J. Neurosci. 31 (2011), 3610–3624, 10.1523/JNEUROSCI.6344-10.2011.
75. Kotter, M.R., Li, W.W, Zhao, C., Franklin, R.J., Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26 (2006), 328–332, 10.1523/JNEUROSCI.2615-05.2006.
76. Kotter, M.R., Setzu, A., Sim, F.J., van Rooijen, N., Franklin, R.J.M., Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 (2001), 204–212, 10.1002/glia.1085.
77. Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M.G., Yong, V.W., Stys, P.K., Tremblay, M.-È., Rivest, S., Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J. Exp. Med. 212 (2015), 481–495, 10.1084/jem.20141656.
78. Larkin, E.C., Rao, G.A., Importance of Fetal and Neonatal Iron: Adequacy for Normal Development of Central Nervous System. Brain, Behavior and Iron in the Infant Diet. 1990.
79. Larsen, P.H., Wells, J.E., Stallcup, W.B., Opdenakker, G., Yong, V.W., Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23 (2003), 11127–11135.
80. Lehnardt, S., Lachance, C., Patrizi, S., Lefebvre, S., Follett, P.L., Jensen, F.E., Rosenberg, P.A., Volpe, J.J., Vartanian, T., The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22 (2002), 2478–2486.
81. Li, W.-W., Setzu, A., Zhao, C., Franklin, R.J.M., Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158 (2005), 58–66, 10.1016/j.jneuroim.2004.08.011.
82. Li, J., Ramenaden, E.R., Peng, J., Koito, H., Volpe, J.J., Rosenberg, P.A., Tumor necrosis factor mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 28 (2008), 5321–5330, 10.1523/JNEUROSCI.3995-07.2008.
83. Loughlin, A.J., Honegger, P., Woodroofe, M.N., Comte, V., Matthieu, J.M., Cuzner, M.L., Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment. J. Neurosci. Res. 37 (1994), 647–653, 10.1002/jnr.490370512.
84. Loughlin, A.J., Copelman, C.A., Hall, A., Armer, T., Young, B.C., Landon, D.N., Cuzner, M.L., Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J. Neurosci. Res. 47 (1997), 384–392.
85. Marmur, R., Kessler, J.A., Zhu, G., Gokhan, S., Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFβ receptors. J. Neurosci. 18 (1998), 9800–9811.
86. Marriott, M.P., Emery, B., Cate, H.S., Binder, M.D., Kemper, D., Wu, Q., Kolbe, S., Gordon, I.R., Wang, H., Egan, G., Murray, S., Butzkueven, H., Kilpatrick, T.J., Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 56 (2008), 686–698, 10.1002/glia.20646.
87. Mason, J.L., Suzuki, K., Chaplin, D.D., Matsushima, G.K., Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21 (2001), 7046–7052.
88. Matute, C., Domercq, M., Sánchez-Gómez, M.-V., Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53 (2005), 212–224, 10.1002/glia.20275.
89. Mayer, M., Bhakoo, K., Noble, M., Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120 (1994), 143–153.
90. McFarland, H.F., Martin, R., Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8 (2007), 913–919, 10.1038/ni1507.
91. McKinnon, R.D., Piras, G., Ida, J.A., Dubois-Dalcq, M., A role for TGF-beta in oligodendrocyte differentiation. J. Cell Biol. 121 (1993), 1397–1407.
92. McTigue, D.M., Tripathi, R., Wei, P., NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J. Neuropathol. Exp. Neurol. 65 (2006), 406–420, 10.1097/01.jnen.0000218447.32320.52.
93. Merrill, J.E., Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev. Neurosci. 13 (1991), 130–137.
94. Merrill, J.E., Benveniste, E.N., Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19 (1996), 331–338.
95. Merson, T.D., Binder, M.D., Kilpatrick, T.J., Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. Neruomol. Med. 12 (2010), 99–132, 10.1007/s12017-010-8112-z.
96. Miron, V.E., Boyd, A., Zhao, J.-W., Yuen, T.J., Ruckh, J.M., Shadrach, J.L., van Wijngaarden, P., Wagers, A.J., Williams, A., Franklin, R.J.M., Ffrench-Constant, C., M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16 (2013), 1211–1218, 10.1038/nn.3469.
97. Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20 (2014), 1126–1167, 10.1089/ars.2012.5149.
98. Moll, N.M., Cossoy, M.B., Fisher, E., Staugaitis, S.M., Tucky, B.H., Rietsch, A.M., Chang, A., Fox, R.J., Trapp, B.D., Ransohoff, R.M., Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch. Neurol. 66 (2009), 44–53, 10.1001/archneurol.2008.512.
99. Nadeau, S., Filali, M., Zhang, J., Kerr, B.J., Rivest, S., Soulet, D., Iwakura, Y., de Rivero Vaccari, J.P., Keane, R.W., Lacroix, S., Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1 and TNF: implications for neuropathic pain. J. Neurosci. 31 (2011), 12533–12542, 10.1523/JNEUROSCI.2840-11.2011.
100. Napoli, I., Neumann, H., Protective effects of microglia in multiple sclerosis. Exp. Neurol. 225 (2010), 24–28, 10.1016/j.expneurol.2009.04.024.
101. Nathan, C., Cunningham-Bussel, A., Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 13 (2013), 349–361, 10.1038/nri3423.
102. Nathaniel, E., Pease, D.C., Regenerative changes in rat dorsal roots following Wallerian degeneration. J. Ultrastruct. Res. 9 (1963), 533–549.
103. Nave, K.-A., Werner, H.B., Myelination of the nervous system: mechanisms and functions. Annu. Rev. Cell Dev. Biol. 30 (2014), 503–533, 10.1146/annurev-cellbio-100913-013101.
104. Neumann, H., Kotter, M.R., Franklin, R.J.M., Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132 (2008), 288–295, 10.1093/brain/awn109.
105. Norton, W.T., Cammer, W., Bloom, B.R., Gordon, S., Neutral proteinases secreted by macrophages degrade basic protein: a possible mechanism of inflammatory demyelination. Adv. Exp. Med. Biol. 100 (1978), 365–381.
106. Omari, K.M., John, G.R., Sealfon, S.C., Raine, C.S., CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128 (2005), 1003–1015.
107. Omari, K.M., John, G., Lango, R., Raine, C.S., Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53 (2006), 24–31.
108. Omari, K.M., Lutz, S.E., Santambrogio, L., Lira, S.A., Raine, C.S., Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am. J. Pathol. 174 (2009), 164–176, 10.2353/ajpath.2009.080350.
109. Padovani-Claudio, D.A., Liu, L., Ransohoff, R.M., Miller, R.H., Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 54 (2006), 471–483, 10.1002/glia.20383.
110. Palazuelos, J., Klingener, M., Aguirre, A., TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J. Neurosci. 34 (2014), 7917–7930, 10.1523/JNEUROSCI.0363-14.2014.
111. Pang, Y., Campbell, L., Zheng, B., Fan, L., Cai, Z., Rhodes, P., Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 166 (2010), 464–475, 10.1016/j.neuroscience.2009.12.040.
112. Patel, J.R., Klein, R.S., Mediators of oligodendrocyte differentiation during remyelination. FEBS Lett. 585 (2011), 3730–3737, 10.1016/j.febslet.2011.04.037.
113. Patel, J.R., McCandless, E.E., CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 11062–11067, 10.1073/pnas.1006301107/-/DCSupplemental.
114. Pavelko, K.D., van Engelen, B.G., Rodriguez, M., Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J. Neurosci. 18 (1998), 2498–2505.
115. Pendleton, J.C., Shamblott, M.J., Gary, D.S., Belegu, V., Hurtado, A., Malone, M.L., McDonald, J.W., Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ. Exp. Neurol. 247 (2013), 113–121, 10.1016/j.expneurol.2013.04.003.
116. Perrin, F.E., Lacroix, S., Avilés-Trigueros, M., David, S., Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration. Brain 128 (2005), 854–866.
117. Perry, V.H., Brown, M.C., Role of macrophages in peripheral nerve degeneration and repair. BioEssays 14 (1992), 401–406, 10.1002/bies.950140610.
118. Perry, V.H., Brown, M.C., Gordon, S., The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J. Exp. Med. 165 (1987), 1218–1223.
119. Piaton, G., Aigrot, M.S., Williams, A., Moyon, S., Tepavcevic, V., Moutkine, I., Gras, J., Matho, K.S., Schmitt, A., Soellner, H., Huber, A.B., Ravassard, P., Lubetzki, C., Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134 (2011), 1156–1167, 10.1093/brain/awr022.
120. Pleasure, D., Abramsky, O., Silberberg, D., Quinn, B., Parris, J., Saida, T., Lipid synthesis by an oligodendroglial fraction in suspension culture. Brain Res. 134 (1977), 377–382.
121. Ramalingam, M., Kim, S.-J., Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J. Neural Transm. 119 (2012), 891–910, 10.1007/s00702-011-0758-7.
122. Rathore, K.I., Redensek, A., David, S., Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1. Glia 60 (2012), 738–750, 10.1002/glia.22303.
123. Reichert, F., Rotshenker, S., Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol. Dis. 12 (2003), 65–72, 10.1016/S0969-9961(02)00008-6.
124. Robinson, S., Miller, R.H., Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216 (1999), 359–368, 10.1006/dbio.1999.9466.
125. Robinson, S., Tani, M., Strieter, R.M., The chemokine growth-regulated oncogene-α promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18 (1998), 10457–10463.
126. Rodriguez, M., Lindsley, M.D., Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology 42 (1992), 348–357.
127. Rodriguez, M., Miller, D.J., Lennon, V.A., Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46 (1996), 538–545.
128. Rosenberg, S.S., Ng, B.K., Chan, J.R., The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol. 16 (2006), 288–294, 10.1111/j.1750-3639.2006.00035.x.
129. Ruckh, J.M., Zhao, J.-W., Shadrach, J.L., van Wijngaarden, P., Rao, T.N., Wagers, A.J., Franklin, R.J.M., Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10 (2012), 96–103.
130. Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M.C., Wieland, F., Ishibashi, S., Nave, K.-A., High cholesterol level is essential for myelin membrane growth. Nat. Neurosci., 2005, 10.1038/nn1426.
131. Schlaepfer, W.W., Hager, H., Ultrastructural studies of INH-induced neuropathy in rats. II. Alteration and decomposition of the myelin sheath. Am. J. Pathol. 45 (1964), 423–433.
132. Schmitz, T., Chew, L.-J., Cytokines and myelination in the central nervous system. ScientificWorldJournal 8 (2008), 1119–1147, 10.1100/tsw.2008.140.
133. Schonberg, D.L., McTigue, D.M., Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp. Neurol. 218 (2009), 64–74, 10.1016/j.expneurol.2009.04.005.
134. Schonberg, D.L., Popovich, P.G., McTigue, D.M., Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 66 (2007), 1124–1135, 10.1097/nen.0b013e31815c2530.
135. Schonberg, D.L., Goldstein, E.Z., Sahinkaya, F.R., Wei, P., Popovich, P.G., McTigue, D.M., Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J. Neurosci. 32 (2012), 5374–5384, 10.1523/JNEUROSCI.3517-11.2012.
136. Schönemeier, B., Kolodziej, A., Schulz, S., Jacobs, S., Hoellt, V., Stumm, R., Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J. Comp. Neurol. 510 (2008), 207–220, 10.1002/cne.21780.
137. Schulz, K., Kroner, A., David, S., Iron efflux from astrocytes plays a role in remyelination. J. Neurosci. 32 (2012), 4841–4847, 10.1523/JNEUROSCI.5328-11.2012.
138. Schwab, M.E., Nogo and axon regeneration. Curr. Opin. Neurobiol. 14 (2004), 118–124, 10.1016/j.conb.2004.01.004.
139. Setzu, A., Lathia, J.D., Zhao, C., Wells, K., Rao, M.S., Ffrench-Constant, C., Franklin, R.J.M., Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006), 297–303, 10.1002/glia.20371.
140. Shamash, S., Reichert, F., Rotshenker, S., The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22 (2002), 3052–3060.
141. Shen, S., Sandoval, J., Swiss, V.A., Li, J., Dupree, J., Franklin, R.J.M., Casaccia-Bonnefil, P., Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci. 11 (2008), 1024–1034, 10.1038/nn.2172.
142. Shigemoto-Mogami, Y., Hoshikawa, K., Goldman, J.E., Sekino, Y., Sato, K., Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J. Neurosci. 34 (2014), 2231–2243, 10.1523/JNEUROSCI.1619-13.2014.
143. Siebert, J.R., Osterhout, D.J., The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J. Neurochem. 119 (2011), 176–188, 10.1111/j.1471-4159.2011.07370.x.
144. Sim, F.J., Zhao, C., Penderis, J., Franklin, R.J.M., The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 22 (2002), 2451–2459.
145. Siqueira Mietto, B., Kroner, A., Girolami, E.I., Santos-Nogueira, E., Zhang, J., David, S., Role of IL-10 in resolution of inflammation and functional recovery after peripheral nerve injury. J. Neurosci. 35 (2015), 16431–16442, 10.1523/JNEUROSCI.2119-15.2015.
146. Smith, K.J., Blakemore, W.F., McDonald, W.I., Central remyelination restores secure conduction. Nature 280 (1979), 395–396.
147. Stankoff, B., Aigrot, M.-S., Noël, F., Wattilliaux, A., Zalc, B., Lubetzki, C., Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 22 (2002), 9221–9227.
148. Syed, Y.A., Baer, A.S., Lubec, G., Hoeger, H., Widhalm, G., Kotter, M.R., Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg. Focus., 24, 2008, E5, 10.3171/FOC/2008/24/3-4/E4.
149. Syed, Y.A., Zhao, C., Mahad, D., Möbius, W., Altmann, F., Foss, F., Sentürk, A., Acker-Palmer, A., Lubec, G., Lilley, K., Franklin, R.J.M., Nave, K.-A., Kotter, M.R.N., Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination. Acta Neuropathol., 2015, 1–18, 10.1007/s00401-015-1521-1.
150. Szuchet, S., Yim, S.H., Monsma, S., Lipid metabolism of isolated oligodendrocytes maintained in long-term culture mimics events associated with myelinogenesis. Proc. Natl. Acad. Sci. U. S. A. 80 (1983), 7019–7023.
151. Talbott, J.F., Cao, Q., Bertram, J., Nkansah, M., Benton, R.L., Lavik, E., Whittemore, S.R., CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp. Neurol. 204 (2007), 485–489, 10.1016/j.expneurol.2006.12.013.
152. Taveggia, C., Feltri, M.L., Wrabetz, L., Signals to promote myelin formation and repair. Nat. Rev. Neurol. 6 (2010), 276–287, 10.1038/nrneurol.2010.37.
153. Tetzlaff, W., Okon, E.B., Karimi-Abdolrezaee, S., Hill, C.E., Joseph, S.S., Plemel, J.R., Ward, P.T., Tsai, E.C., Baptiste, D., Smithson, L.J., Kawaja, M.D., Fehlings, M.G., Kwon, B.K., A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28 (2011), 1611–1682.
154. Thorburne, S.K., Juurlink, B.H., Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 67 (1996), 1014–1022.
155. Todorich, B., Pasquini, J.M., Garcia, C.I., Paez, P.M., Connor, J.R., Oligodendrocytes and myelination: the role of iron. Glia 57 (2009), 467–478, 10.1002/glia.20784.
156. Tofaris, G.K., Patterson, P.H., Jessen, K.R., Mirsky, R., Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. 22 (2002), 6696–6703.
157. Triarhou, L.C., Herndon, R.M., The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord. Arch. Neurol. 43 (1986), 121–125.
158. Trotta, T., Porro, C., Calvellon, R., Panaro, M.A., Biological role of Toll-like receptor-4 in the brain. J. Neuroimmunol. 268 (2014), 1–12, 10.1016/j.jneuroim.2014.01.014.
159. Tsai, H.-H., Frost, E., To, V., Robinson, S., Ffrench-Constant, C., Geertman, R., Ransohoff, R.M., Miller, R.H., The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110 (2002), 373–383.
160. Vallières, N., Berard, J.L., David, S., Lacroix, S., Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53 (2005), 103–113, 10.1002/glia.20266.
161. Vela, J.M., Molina-Holgado, E., Arévalo-Martín, A., Almazán, G., Guaza, C., Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20 (2002), 489–502, 10.1006/mcne.2002.1127.
162. Vora, P., Pillai, P., Mustapha, J., Kowal, C., Shaffer, S., Bose, R., Namaka, M., Frost, E.E., CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signaling. Exp. Neurol. 236 (2012), 259–267, 10.1016/j.expneurol.2012.04.012.
163. Wisniewski, H.M., Bloom, B.R., Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J. Exp. Med. 141 (1975), 346–359.
164. Wrathall, J.R., Li, W., Hudson, L.D., Myelin gene expression after experimental contusive spinal cord injury. J. Neurosci. 18 (1998), 8780–8793.
165. Wu, Q., Miller, R.H., Ransohoff, R.M., Robinson, S., Bu, J., Nishiyama, A., Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J. Neurosci. 20 (2000), 2609–2617.
166. Xu, X.-M., Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous Schwann cell transplantation in patients with spinal cord injuries. Neural Regen. Res. 7 (2012), 1685–1687, 10.3969/j.issn.1673-5374.2012.22.001.
167. Ydens, E., Lornet, G., Smits, V., Goethals, S., Timmerman, V., Janssens, S., The neuroinflammatory role of Schwann cells in disease. Neurobiol. Dis. 55 (2013), 95–103, 10.1016/j.nbd.2013.03.005.
168. Zalc, B., The acquisition of myelin: an evolutionary perspective. Brain Res., 2015, 1–7, 10.1016/j.brainres.2015.09.005.
169. Zarruk, J.G., Berard, J.L., Santos dos, R.P., Kroner, A., Lee, J., Arosio, P., David, S., Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation. Neurobiol. Dis., 2016, 1–15, 10.1016/j.nbd.2015.02.001.
170. Zhang, P., Chebath, J., Lonai, P., Revel, M., Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling. Stem Cells 22 (2004), 344–354.
171. Zhang, X., Surguladze, N., Slagle-Webb, B., Cozzi, A., Connor, J.R., Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54 (2006), 795–804, 10.1002/glia.20416.
172. Zhang, F., Yao, S.-Y., Whetsell, W.O., Sriram, S., Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination. Glia 61 (2013), 1261–1273, 10.1002/glia.22513.
173. Zhao, C., Li, W.-W., Franklin, R.J.M., Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol. Aging 27 (2006), 1298–1307.